Back
Daré Bioscience, Inc. Stock Predictions
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
25
DARE
Daré Bioscience, Inc.
Last Price:
$1.78
Seasonality Move:
23.9%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiDaré Bioscience, Inc. Stock Forecast
-
Is Daré Bioscience, Inc. Stock Undervalued?The current Daré Bioscience, Inc. [DARE] share price is $1.75. The Score for DARE is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
DARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Daré Bioscience, Inc. Stock Go Up Next Year?
Data Unavailable
Daré Bioscience, Inc. Stock Rating
Data Unavailable
Daré Bioscience, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
darebioscience.com
52-Week Data
52-Week High:
9.19
52-Week Low:
1.61
Prediction Charts
Market Cap:
24.9M
Price in USD:
1.75
Volume:
78.5K
Beta:
1.45
Technical Analysis
SMA50:
1.97
SMA100:
2.10
SMA200:
2.50
52-Wk Change:
-46.8%
Stock Predictions
-
Is Daré Bioscience, Inc. stock public?Yes, Daré Bioscience, Inc. is a publicly traded company.
-
What is the Daré Bioscience, Inc. stock quote today?The Daré Bioscience, Inc. stock price is 1.75 USD today.
-
How to buy Daré Bioscience, Inc. stock online?You can buy Daré Bioscience, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-13 | 2.00 | 1.89 | 2.01 | 1.88 |
| Nov-14 | 1.94 | 1.86 | 1.97 | 1.80 |
| Nov-17 | 1.85 | 1.81 | 1.92 | 1.80 |
| Nov-18 | 1.80 | 1.78 | 1.81 | 1.76 |
| Nov-19 | 1.78 | 1.71 | 1.84 | 1.65 |
| Nov-20 | 1.73 | 1.63 | 1.74 | 1.62 |
| Nov-21 | 1.64 | 1.68 | 1.69 | 1.61 |
| Nov-24 | 1.73 | 1.79 | 1.82 | 1.72 |
| Nov-25 | 1.79 | 1.77 | 1.83 | 1.74 |
| Nov-26 | 1.78 | 1.81 | 1.85 | 1.70 |
| Nov-28 | 1.84 | 1.84 | 1.86 | 1.79 |
| Dec-1 | 1.82 | 1.67 | 1.84 | 1.67 |
| Dec-2 | 1.73 | 1.72 | 1.78 | 1.64 |
| Dec-3 | 1.75 | 1.75 | 1.78 | 1.70 |
Daré Bioscience, Inc. Earnings
Data Unavailable
Daré Bioscience, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.87 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.20 per share, and an increase next year of $1.31 per share.
* Daré Bioscience, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.